Results 201 to 210 of about 374,595 (258)

Tissue distribution and bioactivity of amphotericin B administered in liposomes to cancer patients [PDF]

, 1991
Nadia Collette, P. Van der Auwera, F. Meunier, Christine Lambert, Jean‐Paul Sculier, A. Coune   +5 more
openalex   +1 more source

Overcoming resistance of Candida albicans using photodynamic inactivation

Photochemistry and Photobiology, EarlyView.
The rising resistance of Candida albicans to conventional antifungals, like Amphotericin B (AmB), highlights the need for alternative treatments. This study evaluated the antifungal effectiveness of combining AmB with photodynamic inactivation (PDI) using curcumin as a photosensitizer.
Gabriela Gomes Guimarães, Jennifer Soares, Anna Luiza Resende, Isabella Gonçalves, Kate Blanco, Vanderlei Bagnato   +5 more
wiley   +1 more source

Comparison of the Activity of Free and Liposomal Amphotericin B In Vitro and in a Model of Systemic and Localized Murine Candidiasis [PDF]

, 1994
Stephan Pahls, Andreas Schaffner
openalex   +1 more source

Infections Management in the Lung Transplant Setting in Italy: A Web‐Survey

Transplant Infectious Disease, Volume 27, Issue 2, March/April 2025.
A web survey has revealed significant variation in infection management practices across Italian lung transplant centers. These differences encompass key aspects of infection prevention and control, including antibiotic protocols and cytomegalovirus prophylaxis, underscoring a lack of consistency in fundamental strategies.
Andrea Lombardi, Paolo Grossi, Malgorzata Mikulska, Maddalena Giannella, Renato Pascale, Serena Marinello, Francesca Montagnani, Elena Seminari, Silvia Corcione, Alessandra Bandera, Alessandro Bertani, Alessandra Mularoni, for the Infection Prevention and Treatment Working Group of the LUNG‐SITO study group   +12 more
wiley   +1 more source

iPSC-derived exosomes as amphotericin B carriers: a promising approach to combat cryptococcal meningitis. [PDF]

Front Microbiol
Zhao J, Fang W, Gao Y, Chen J, Wang G, Gu J.   +5 more
europepmc   +1 more source

Synthesis and structure-activity relationships of amides of amphotericin B.

, 1982
Andrzej B. Jarzębski, L. Falkowski, E. Borowski   +2 more
openalex   +2 more sources

Influence of phospholipid/amphotericin B ratio and phospholipid type on in vitro renal cell toxicities and fungicidal activities of lipid-associated amphotericin B formulations [PDF]

, 1992
Véronique Joly, Jacques Bolard, L Saint-Julien, C Carbon, P. Yéni   +4 more
openalex   +1 more source

Antifungal activity of essential oils and their potential synergistic effect with amphotericin B. [PDF]

Sci Rep
Yuan X, Cao D, Xiang Y, Jiang X, Liu J, Bi K, Dong X, Wu T, Zhang Y.   +8 more
europepmc   +1 more source

Aspergillus After Lung Transplantation: Prophylaxis, Risk Factors, and the Impact on Chronic Lung Allograft Dysfunction

Transplant Infectious Disease, EarlyView.
Out of 274 lung transplant (LTx) patients, 89 (32%) developed invasive aspergillosis IA. Factors associated with IA were mycophenolate mofetil use, airway stenosis, Aspergillus cultured pre‐LTx, chronic lung allograft dysfunction (CLAD), and acute rejection. The role of nebulized amphotericin B and statins for prevention of IA remains unclear. ABSTRACT
Johanna P. van Gemert, Ger Jan Fleurke, Onno W. Akkerman, C. Tji. Gan, Willie N. Steenhuis, Huib A. M. Kerstjens, Erik A. M. Verschuuren, Douwe F. Postma   +7 more
wiley   +1 more source

Correction: Development of amphotericin B inclusion complex formulation in dissolvable microarray patches for intravaginal delivery. [PDF]

Daru
Burhanuddin H, Enggi CK, Tangdilintin F, Saputra RR, Putra PP, Sartini S, Aliyah A, Agustina R, Domínguez-Robles J, Aswad M, Permana AD.   +10 more
europepmc   +1 more source